Managing Partner of the Laboratory for Biotechnological Research of 3D Bioprinting Solutions Yousef D. Hesuani will give a lecture “3D Bioprinting: At the Frontier of the Third Industrial Revolution” as part of the “Industries of the 21st Century” project on September 23 at 7 p.m.

3D bioprinting is rapidly developing worldwide. According to the Gartner’s latest research, bioprinting will be experiencing rushing development in the next 5-10 years, specifically in the fabrication of live human tissues for transplantation and in support of life sciences studies and research.

Not very long ago the opponents of bioprinting argued that human organs are enormously complicated and could not be printed. But Russian researchers from the Laboratory for Biotechnological Research of 3D Bioprinting Solutions have turned the fantastic idea into reality. Using Russia’s first bioprinter they printed a whole organ -- a mouse thyroid gland. Nobody in the world had managed that ever before, despite successes achieved in various countries in printing fragments of human organs.

These matters and the drastic changes awaiting the world in the next 15 years due to the development of bioprinting will be discussed at the “Boiling Point” on September 23, 2015 at 7 p.m.

“Certain success in the restoration of lost organs or their functions can be achieved in the next 15 years, -- Managing Partner of the Laboratory for Biotechnological Research of 3D Bioprinting Solutions Yousef D. Hesuani said. -- Different approaches and techniques (such as 3D bioprinting) may be used in regenerative medicine, and, apparently, these technologies will be based on using the patient’s own cells (for example, induced pluripotent stem cells). Naturally, if the task of restoring organs or their functions by way of fabricating artificial organ constructs is achieved, the organ fabrication process will be automated and we may witness the appearance of organ factories.”

The Laboratory for Biotechnological Research of 3D Bioprinting Solutions” is the only private company in Russia developing its own 3D bioprinting technology, which has created its won bioprinter of original design.